Therapeutic Asset Ratings

435 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Venetoclax Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative	OHSU Knight Cancer Institute	P1/2	CCC (54)
Venetoclax Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable	OHSU Knight Cancer Institute	P1/2	CCC (54)
Venetoclax Primary Myelofibrosis	OHSU Knight Cancer Institute	P1/2	CCC (54)
EXEMESTANE Ovarian Cancer	OHSU Knight Cancer Institute	P3	CCC (53)
Abemaciclib Advanced Malignant Solid Neoplasm	OHSU Knight Cancer Institute	P2	CCC (53)
Abemaciclib Exocrine Pancreatic Carcinoma	OHSU Knight Cancer Institute	P2	CCC (53)
Abemaciclib Prostate Carcinoma	OHSU Knight Cancer Institute	P2	CCC (53)
Abemaciclib Sarcoma	OHSU Knight Cancer Institute	P2	CCC (53)
Copanlisib Hematopoietic And Lymphoid System Neoplasm	OHSU Knight Cancer Institute	P2	CCC (53)
Copanlisib Refractory Malignant Neoplasm	OHSU Knight Cancer Institute	P2	CCC (53)
Copanlisib Refractory Multiple Myeloma	OHSU Knight Cancer Institute	P2	CCC (53)
Entrectinib Breast Cancer	OHSU Knight Cancer Institute	P2	CCC (53)
EXEMESTANE Advanced Malignant Solid Neoplasm	OHSU Knight Cancer Institute	P2	CCC (53)
EXEMESTANE Ovarian Carcinoma	OHSU Knight Cancer Institute	P2	CCC (53)
EXEMESTANE Exocrine Pancreatic Carcinoma	OHSU Knight Cancer Institute	P2	CCC (53)
EXEMESTANE Prostate Carcinoma	OHSU Knight Cancer Institute	P2	CCC (53)
EXEMESTANE Sarcoma	OHSU Knight Cancer Institute	P2	CCC (53)
EXEMESTANE Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	P2	CCC (53)
Gdc-0449 Ovarian Cancer	OHSU Knight Cancer Institute	P2	CCC (53)
Olanzapine Biliary Tract Cancer	OHSU Knight Cancer Institute	P2	CCC (53)
Olanzapine Carcinoma Of Esophagus	OHSU Knight Cancer Institute	P2	CCC (53)
Olanzapine Lung Carcinoma	OHSU Knight Cancer Institute	P2	CCC (53)
Olanzapine Colorectal Carcinoma	OHSU Knight Cancer Institute	P2	CCC (53)
Olanzapine Gastric Adenocarcinoma	OHSU Knight Cancer Institute	P2	CCC (53)
Olanzapine Hepatocellular Carcinoma	OHSU Knight Cancer Institute	P2	CCC (53)

Showing 226 to 250 of 435 assets

PreviousPage 10 of 18Next